Javascript must be enabled to continue!
Systemic inflammation biomarkers during angioedema attacks in hereditary angioedema
View through CrossRef
BackgroundHereditary angioedema (HAE) is a rare disease characterized by localized and self-limited angioedema (AE) attacks. A local increase of bradykinin (BK) mediates AE attacks in HAE, however the role of inflammation in HAE has been poorly explored We aim to analyze the role of inflammatory mediators in HAE patients during AE attacks.MethodsPatients with a confirmed HAE diagnosis due to C1 inhibitor deficiency (HAE-C1INH) or patients F12 gene mutations (HAE-FXII) attending to our outpatient clinic between November-2019 and May-2022 were included. Demographic and clinical characteristics were analyzed. Blood samples were collected both during symptom-free periods (baseline) and during HAE attacks, and acute phase reactants (APR), such as serum amyloid A (SAA), erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), D-Dimer and white blood cells were measured.ResultsSeventy-eight patients were enrolled in the study, with a predominant representation of women (76%, n=59), and a mean age of 47.8 years (range 6–88). Among them, 67% (n=52) of patients had HAE-C1INH (46 classified as type 1 and 6 as type 2) while 33% (n=26) had HAE-FXII. During attack-free periods, the majority of patients exhibited normal levels of SAA, ESR, D-dimer, ACE and WCC. However, in a subset of patients (16% for SAA, 18% for ESR, and 14.5% for D-dimer), elevations were noted at baseline. Importantly, during HAE attacks, significant increases were observed in SAA in 88% of patients (p< 0.0001 vs. baseline), in ESR in 65% (p= 0.003 vs. baseline) and D-dimer in 71% (p=0.001 vs. baseline) of the patients. A comparison between baseline and acute attack levels in 17 patients revealed significant differences in SAA AA (p<0. 0001), ESR (p<0.0001) and D-dimer (p= 0.004). No significant differences were observed in CRP (p=0.7), ACE (p=0.67) and WCC (p=0.54). These findings remained consistent regardless of HAE type, disease activity or location of angioedema.ConclusionThe systemic increase in APR observed during HAE attacks suggests that inflammation extends beyond the localized edematous area. This finding underscores the potential involvement of inflammatory pathways in HAE and highlights the need for further investigation into their role in the pathophysiology of HAE.
Title: Systemic inflammation biomarkers during angioedema attacks in hereditary angioedema
Description:
BackgroundHereditary angioedema (HAE) is a rare disease characterized by localized and self-limited angioedema (AE) attacks.
A local increase of bradykinin (BK) mediates AE attacks in HAE, however the role of inflammation in HAE has been poorly explored We aim to analyze the role of inflammatory mediators in HAE patients during AE attacks.
MethodsPatients with a confirmed HAE diagnosis due to C1 inhibitor deficiency (HAE-C1INH) or patients F12 gene mutations (HAE-FXII) attending to our outpatient clinic between November-2019 and May-2022 were included.
Demographic and clinical characteristics were analyzed.
Blood samples were collected both during symptom-free periods (baseline) and during HAE attacks, and acute phase reactants (APR), such as serum amyloid A (SAA), erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), D-Dimer and white blood cells were measured.
ResultsSeventy-eight patients were enrolled in the study, with a predominant representation of women (76%, n=59), and a mean age of 47.
8 years (range 6–88).
Among them, 67% (n=52) of patients had HAE-C1INH (46 classified as type 1 and 6 as type 2) while 33% (n=26) had HAE-FXII.
During attack-free periods, the majority of patients exhibited normal levels of SAA, ESR, D-dimer, ACE and WCC.
However, in a subset of patients (16% for SAA, 18% for ESR, and 14.
5% for D-dimer), elevations were noted at baseline.
Importantly, during HAE attacks, significant increases were observed in SAA in 88% of patients (p< 0.
0001 vs.
baseline), in ESR in 65% (p= 0.
003 vs.
baseline) and D-dimer in 71% (p=0.
001 vs.
baseline) of the patients.
A comparison between baseline and acute attack levels in 17 patients revealed significant differences in SAA AA (p<0.
0001), ESR (p<0.
0001) and D-dimer (p= 0.
004).
No significant differences were observed in CRP (p=0.
7), ACE (p=0.
67) and WCC (p=0.
54).
These findings remained consistent regardless of HAE type, disease activity or location of angioedema.
ConclusionThe systemic increase in APR observed during HAE attacks suggests that inflammation extends beyond the localized edematous area.
This finding underscores the potential involvement of inflammatory pathways in HAE and highlights the need for further investigation into their role in the pathophysiology of HAE.
Related Results
Ketorolac induced non allergic angioedema: A case report
Ketorolac induced non allergic angioedema: A case report
Non- Steroidal anti-inflammatory drugs (NSAIDs) are among the most commonly prescribed category of drugs. NSAIDs are the main cause of allergic reactions both in adults and childre...
Myoferline gene mutation сan be associated with recurrent angioedema
Myoferline gene mutation сan be associated with recurrent angioedema
Hereditary angioedema is a rare genetically determined disease characterized by the recurrent angioedema of various localizations with no response to systemic glucocorticosteroids,...
Deception-Based Security Framework for IoT: An Empirical Study
Deception-Based Security Framework for IoT: An Empirical Study
<p><b>A large number of Internet of Things (IoT) devices in use has provided a vast attack surface. The security in IoT devices is a significant challenge considering c...
Etiology, Recent Advances, and Clinical Trials Data for the Treatment of Angioedema: A Review
Etiology, Recent Advances, and Clinical Trials Data for the Treatment of Angioedema: A Review
Angioedema is a health issue that affects parts of the body like the upper pulmonary
and gastric pathways and is identified by abrupt, nonpitting enlargement of the skin, mucous me...
Bradykinin B2 Receptor Antagonist off Label Use in Short-Term Prophylaxis in Hereditary Angioedema
Bradykinin B2 Receptor Antagonist off Label Use in Short-Term Prophylaxis in Hereditary Angioedema
Hereditary angioedema type I (HAE-C1-INH) is an inherited disorder characterized by repeated severe angioedema attacks mostly triggered by traumas, emotional stress, increased estr...
A challenging case of bradykinin-mediated angioedema with airway obstruction: management and therapeutic strategies
A challenging case of bradykinin-mediated angioedema with airway obstruction: management and therapeutic strategies
Angioedema is a potentially life-threatening condition that can have an allergic origin, usually mediated by histamine or a non-allergic origin, mediated by bradykinin. The distinc...
Angioedema Associated with Aspirin and Rofecoxib
Angioedema Associated with Aspirin and Rofecoxib
OBJECTIVE:
To report the probable association of angioedema with aspirin therapy and the selective cyclooxygenase-2 (COX-2) inhibitor rofecoxib.
...
Prodromes as Predictors of Hereditary Angioedema Attacks
Prodromes as Predictors of Hereditary Angioedema Attacks
Background:
Prodromes are repetitive complexes of signs
or symptoms portending attacks of certain chronic diseases. Recent data
suggest that a large majority of p...

